Antibody-dependent passive protection of mucosal surfaces
| Autor: | Jiri Mestecky |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Female circumcision
medicine.drug_class 030231 tropical medicine Immunology Monoclonal antibody 03 medical and health sciences 0302 clinical medicine Immune system Immunology and Allergy Medicine Animals 030212 general & internal medicine Respiratory system Immunity Mucosal Short survival Pharmacology Mucous Membrane biology business.industry External secretions Antibodies Monoclonal Gastrointestinal Tract Polyclonal antibodies Immune System biology.protein Female Antibody business |
| Zdroj: | Human vaccinesimmunotherapeutics. 18(2) |
| ISSN: | 2164-554X |
| Popis: | Extensive experiments performed mostly in a variety of animal models convincingly demonstrated the protective effect of polyclonal or monoclonal antibodies administered by the mucosal route. Because of the independence of the mucosal and systemic compartments of the immune system, antibodies from the circulation are not effectively transported in sufficient quantities into external secretions. Nevertheless, local application of antibodies of the desired specificity to mucosal membranes of the respiratory, gastrointestinal, and female genital tracts protected experimental animals from the subsequent challenge by corresponding viral or bacterial pathogens. Thus, generation of monoclonal antibodies of desired specificity and the selection of delivery systems to extend their otherwise short survival on some mucosal surfaces are essential aims of their usability in humans for the effective prevention of mucosally acquired infectious diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|